menu search

Retransmission: defence to present at the 9th annual immuno-oncology 360º summit in new-york february 7-10, 2023

Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the...

January 23, 2023, 3:15 am

Covid, shmovid: this could be the next big growth story for moderna stock

Moderna could follow closely behind Pfizer and GSK in entering the lucrative RSV vaccine market....

January 21, 2023, 6:04 am

Defence to present at the 9th annual immuno-oncology 360 summit in new-york february 7-10, 2023

Vancouver, British Columbia--(Newsfile Corp. - January 20, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the...

January 20, 2023, 4:30 pm

Moderna and pfizer race to release rsv vaccines

Two of the largest vaccine producers have engaged in the rapid development of RSV v...

January 20, 2023, 10:14 am

Gsk faces new rsv vaccine competitor after moderna data, says barclays

GSK is facing a new competitor for its respiratory syncytial virus RSV vaccine after Moderna published ...

January 20, 2023, 3:55 am

Why shares of vaxxinity jumped this week

Investors are hoping the company's COVID-19 vaccine will turn the company from a clinical-stage biotech...

January 19, 2023, 2:04 pm

Ubs: curevac has a ‘potentially competitive mrna platform'

CureVac's CVAC, +8.44% promising Phase 1 data for flu and COVID-19 vaccine candidates is a signal to in...

January 19, 2023, 1:56 pm

Pharmaceutical stocks pfizer, gsk, moderna come close to cracking a multibillion-dollar rsv vaccine market

Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching t...

January 19, 2023, 1:41 pm

J&j (jnj) discontinues hiv vaccine phase iii mosaico study

J&J (JNJ) discontinues phase III study on its investigational HIV vaccine regimen, which shows that the...

January 19, 2023, 9:02 am

Sanofi ceo: real breakthrough in rsv treatment is 'right around the corner'

Paul Hudson, Sanofi CEO, joins 'Squawk Box' to discuss the company's product pipeline, Hudson's take on the trust the public have for v...

January 19, 2023, 8:37 am

J&j discontinues hiv trial in latest setback to vaccine pursuit

Johnson & Johnson (NYSE:JNJ)'s wholly-owned pharmaceutical company Janssen Pharmaceuticals and its global research partners have discontinued their P...

January 19, 2023, 2:57 am

Gritstone bio to participate in upcoming investor conferences

EMERYVILLE, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop t...

January 18, 2023, 10:30 pm

Pfizer ceo on vaccine developments

Pfizer's CEO Albert Bourla says he sees an MRNA flu shot coming this year. Bourla spoke to Bloomberg from the World Economic Forum in Davos....

January 18, 2023, 5:55 pm

Gritstone bio to participate in upcoming investor conferences

EMERYVILLE, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop th...

January 18, 2023, 5:30 pm

Federal reserve says powell has tested positive for covid-19

The Fed says Powell has mild Covid-19 symptoms, that he's up-to-date on vaccines and is working remo...

January 18, 2023, 3:33 pm

Angion (angn) down on merger agreement with private biotech

Angion (ANGN) inks a definitive merger agreement with privately-held Elicio Therapeutics. The combined company's lead pipeline candidate will be ELI-0...

January 18, 2023, 2:18 pm

Moderna's mrna rsv vaccine propels stock gains

Michael Yee, managing director at Jefferies, joins 'The Exchange' to discuss what's driving Moderna's stock activity, the unique mRNA technology behin...

January 18, 2023, 2:07 pm

Pfizer ceo albert bourla discusses new vaccines in the pipeline

Pfizer CEO Albert Bourla speaks with CNBC's Sara Eisen at the World Economic Forum in Davos about China's fight against Covid, new v...

January 18, 2023, 1:55 pm

J&j's hiv vaccine fails phase 3 clinical trial

Johnson & Johnson's JNJ, -1.17% experimental HIV vaccine is safe but not effective, and the late-stage ...

January 18, 2023, 12:54 pm

Moderna ceo on vaccines, mutation risk

Moderna CEO Stephane Bancel says the current risk of virus mutations out of China are not high. He speaks to Bloomberg from the World Economic Forum i...

January 18, 2023, 12:44 pm


Search within

Pages Search Results: